Steglujan ema approval date?

When was Steglujan (ertugliflozin/sitagliptin) approved by the FDA?

Steglujan received FDA approval on December 22, 2017. [1]

Is that the approval date for the first-ever product, or later label updates?

The date above is the initial FDA approval date for Steglujan as a marketed medicine. Additional labeling changes (for new indications, dosing, or safety updates) can occur after first approval, but they are different from the approval date of the product itself. [1]

What is the “approval date” people usually mean for search or insurance coverage?

Most searches for “Steglujan approval date” refer to the FDA first approval date (the date the product was first cleared for marketing). Coverage policies and formulary decisions may later reference that date, but they typically use the original approval timeline as the anchor. [1]

Where can I verify this date?

You can verify Steglujan’s FDA approval information on DrugPatentWatch.com. [1]

Sources

[1] https://www.drugpatentwatch.com/p/steglujan